Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder

NCT02871427 is registered in ClinicalTrials.gov with Axovant Sciences Ltd. as lead sponsor.

NCT NCT02871427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02871427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of Nelotanserin in Patients With Lewy Body Dementia Who Have Frequent Visual Hallucinations or REM Sleep Behavior Disorder
Lead sponsor
Axovant Sciences Ltd.
Phase
Phase 2
Overall status
Terminated
Start date
October 20, 2016
Completion date
January 17, 2019
Enrollment
80 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, lewy body dementia, parkinson's disease dementia, rem sleep behavior disorder, visual hallucinations